Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
April 02 2019 - 6:00AM
Summit Therapeutics plc (‘Summit’ or the
‘Company’)
Summit Therapeutics to Present at H. C. Wainwright & Co.
Global Life Sciences Conference
Oxford, UK, and Cambridge, MA, US, 2 April
2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a
leader in new mechanism antibiotic innovation, announces that Mr
Glyn Edwards, Chief Executive Officer, will present at the H. C.
Wainwright & Co. Global Life Sciences Conference on 8 April
2019 at 4:10pm BST in London.
A live webcast of the presentation will be
available in the Investors section of the Company's website,
www.summitplc.com. A replay of the webcast will be available from
the same location soon after the live presentation.
About Summit Therapeutics Summit
Therapeutics is a leader in antibiotic innovation. Our new
mechanism antibiotics are designed to become the new standards of
care for the benefit of patients, and create value for payors and
healthcare providers. We are currently developing new mechanism
antibiotics for C. difficile infection and gonorrhoea and are using
our proprietary Discuva Platform to expand our pipeline. For more
information, visit www.summitplc.com and follow us on Twitter
@summitplc.
Contacts
Summit |
|
|
Glyn Edwards / Richard Pye (UK
office) |
Tel: |
44 (0)1235 443 951 |
Michelle Avery (US office) |
|
+1 617 225 4455 |
|
|
|
Cairn Financial Advisers LLP (Nominated
Adviser) |
Tel: |
+44 (0)20 7213 0880 |
Liam Murray / Tony Rawlinson |
|
|
|
|
|
N+1 Singer (Joint Broker) |
Tel: |
+44 (0)20 7496 3000 |
Aubrey Powell / Jen Boorer, Corporate FinanceTom
Salvesen, Corporate Broking |
|
|
|
|
|
Bryan Garnier & Co Limited (Joint
Broker) |
Tel: |
+44 (0)20 7332 2500 |
Phil Walker / Dominic Wilson |
|
|
MSL Group (US) |
Tel: |
+1 781 684 6557 |
Jon Siegal |
|
summit@mslgroup.com |
|
|
|
Consilium Strategic Communications
(UK) |
Tel: |
+44 (0)20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Jessica Hodgson
/ |
|
summit@consilium-comms.com |
Lindsey Neville |
|
|
-END-
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Summit Therapeutics (NASDAQ:SMMT)
Historical Stock Chart
From Jul 2023 to Jul 2024